Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?

被引:8
作者
De Moerloose, P [1 ]
Reber, G [1 ]
机构
[1] Hop Cantonal Geneva, Haemostasis Unit, Div Angiol & Hemostasis, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1111/j.1538-7836.2004.00811.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:1071 / 1073
页数:3
相关论文
共 29 条
[1]
Arnout J, 1999, THROMB HAEMOSTASIS, V81, P929
[2]
Arnout J, 2001, THROMB HAEMOSTASIS, V86, P83
[3]
ARNOUT J, 2002, ISTH SCI STANDARDISA
[4]
Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations [J].
Avcin, T ;
Cimaz, R ;
Meroni, PL .
LUPUS, 2002, 11 (01) :4-10
[5]
CABIEDES J, 1995, J RHEUMATOL, V22, P1899
[6]
Which are the best biological markers of the antiphospholipid syndrome? [J].
Carreras, LO ;
Forastiero, RR ;
Martinuzzo, ME .
JOURNAL OF AUTOIMMUNITY, 2000, 15 (02) :163-172
[7]
Beta-2-glycoprotein I antibodies in patients with thrombosis [J].
Ebeling, F ;
Pettersson, T ;
Muukkonen, L ;
Vahtera, E ;
Rasi, V .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2003, 63 (02) :111-118
[8]
Assessing the usefulness of anticardiolipin antibody assays - A cautious approach is suggested by high variation and limited consensus in multilaboratory testing [J].
Favaloro, EJ ;
Silvestrini, R .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) :548-557
[9]
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature [J].
Galli, M ;
Luciani, D ;
Bertolini, G ;
Barbui, T .
BLOOD, 2003, 101 (05) :1827-1832
[10]
Galli M, 1999, THROMB HAEMOSTASIS, V81, P695